(Q33195001)

23 July 2017

1 reference

title

Oral and intestinal mucositis - causes and possible treatments (English)

1 reference

23 July 2017

Oral and intestinal mucositis — causes and possible treatments (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

1 April 2024

author name string

M. Duncan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616150

1 April 2024

G. Grant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616150

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

23 July 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01784.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616150

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01784.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01784.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Alimentary Pharmacology & Therapeutics

1 April 2024

published in

1 reference

23 July 2017

18

1 reference

23 July 2017

853-874

1 reference

23 July 2017

9

1 reference

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

23 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Treatment-induced mucositis: an old problem with new remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Prevention and management of mucositis in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Identification of a putative intestinal stem cell and early lineage marker; musashi-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Epidermal growth factor: a probable oral and digestive health protector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The ecology of Staphylococcus species in the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The radiotherapeutic injury--a complex 'wound'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Innate antiviral defenses in body fluids and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Defensin antimicrobial peptides in the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Severe toxicity related to the 5-fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Sucralfate in the prevention of radiation-induced oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Granulocyte macrophage-colony stimulating factor and oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. A phase II study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The effects of keratinocyte growth factor in preclinical models of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Cell kinetic studies in the murine ventral tongue epithelium: mucositis induced by radiation and its protection by pretreatment with keratinocyte growth factor (KGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Antimicrobial therapy to prevent or treat oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Effect of NASA light-emitting diode irradiation on wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The intestinal epithelial stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Getting to the guts of enteroendocrine differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Mechanisms of myofibroblast activity and phenotypic modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Crohn's disease and the NOD2 gene: a role for paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Metabolism and mechanism of action of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Radiation induced cytochrome c release causes loss of rat colonic fluid absorption by damage to crypts and pericryptal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Modulation of specific intestinal epithelial progenitors by enteric neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Effects of keratinocyte growth factor (KGF) on gut growth and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Metabolic support of the gastrointestinal tract: potential gut protection during intensive cytotoxic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Clarithromycin attenuates cyclophosphamide-induced mucositis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

The use of glutamine in the treatment of gastrointestinal disorders in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Glutamine and the preservation of gut integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, ran

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01784.X

Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Tissue kinetics in mouse tongue mucosa during daily fractionated radiotherapy

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The effect of keratinocyte growth factor on healing of manifest radiation ulcers in mouse tongue epithelium

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Imiminohistochemical and Quantitative Changes in Salivary EGF, Amylase and Haptocorrin following Radiotherapy for Oral Cancer

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Oral flora and pathogenic organisms

1 April 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Development of oral bacterial flora in young children

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The gene expression sequence of radiated mucosa in an animal mucositis model

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Response of mouse oral mucosa to repeated doses of bleomycin

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Modification of oral mucositis by keratinocyte growth factor: single radiation exposure

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Mechanisms and modulation of intestinal epithelial repair

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Oral colonization by Candida albicans

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Secretion of TFF-peptides by human salivary glands

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Hepatocyte growth factor (HGF) system in gingiva: HGF activator expression by gingival epithelial cells.

1 April 2024

48

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Aging and salivary cytokine concentrations as predictors of whole saliva flow rates among women: a preliminary study

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Basic fibroblast growth factor in human saliva decreases with aging

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy

1 April 2024

51

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck

1 April 2024

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies

1 April 2024

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 April 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial

1 April 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

1 April 2024

63

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene

1 April 2024

64

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Comparison of in vivo murine intestinal radiation protection by E-prostaglandins

1 April 2024

65

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.

1 April 2024

66

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism.

1 April 2024

67

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation

1 April 2024

69

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report

1 April 2024

71

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy

1 April 2024

73

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters

1 April 2024

81

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Keratinocyte growth factor promotes alveolar epithelial cell DNA repair after H2O2 exposure

1 April 2024

85

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy

1 April 2024

89

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial

1 April 2024

90

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation

1 April 2024

98

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Chemoprotective and radioprotective effects of amifostine: an update of clinical trials

1 April 2024

100

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Pilot study of laser effects on oral mucositis in patients receiving chemotherapy

1 April 2024

104

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Myofibroblasts. II. Intestinal subepithelial myofibroblasts

1 April 2024

105

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo

1 April 2024

112

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The new peptide hormones of the gut and their clinical significance

1 April 2024

115

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Gut instincts: thoughts on intestinal epithelial stem cells

1 April 2024

116

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The intestinal stem cell niche: there grows the neighborhood

1 April 2024

117

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine

1 April 2024

118

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

1 April 2024

120

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Epithelial migration in the colon: filling in the gaps

1 April 2024

123

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression

1 April 2024

129

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats

1 April 2024

130

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Light and scanning electron microscopic observations of the effects of sublethal doses of methotrexate on the rat small intestine

1 April 2024

131

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat

1 April 2024

136

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Minireview: the glucagon-like peptides

1 April 2024

137

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Biological actions and therapeutic potential of the glucagon-like peptides

1 April 2024

141

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis

1 April 2024

143

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor

1 April 2024

145

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The effects of repeated doses of keratinocyte growth factor on cell proliferation in the cellular hierarchy of the crypts of the murine small intestine

1 April 2024

146

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract

1 April 2024

147

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor

1 April 2024

148

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer

1 April 2024

151

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury

1 April 2024

152

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Epidermal growth factor enhances intestinal mitotic activity and DNA content after acute abdominal radiation

1 April 2024

155

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Epidermal growth factor enhances repair of rat intestinal mucosa damaged by oral administration of methotrexate

1 April 2024

156

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate.

1 April 2024

159

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Effects of insulin-like growth factor-I administration on radiation enteritis in rats

1 April 2024

160

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications

1 April 2024

161

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats

1 April 2024

164

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Protective effect of enriched diet plus growth hormone administration on radiation-induced intestinal injury and on its evolutionary pattern in the rat.

1 April 2024

166

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Growth hormone and nutrition as protective agents against methotrexate induced enteritis

1 April 2024

167

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis

1 April 2024

174

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation

1 April 2024

175

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Elemental diets in the repair of small intestinal damage

1 April 2024

176

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill

1 April 2024

178

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer

1 April 2024

179

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy

1 April 2024

180

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

Nutritional and metabolic support in patients undergoing bone marrow transplantation

1 April 2024

181

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01784.X

1 April 2024

Identifiers

1 reference

23 July 2017

1 reference